Aditx Therapeutics, Inc. (Aditxt) Announces Closing of Initial Public Offering

The underwriters continue to hold a 45-day option to purchase up to an additional 184,000 shares of common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.